Allopurinol in Acute Gout

Université de Sherbrooke

Status: Withdrawn

Conditions: Gout

Treatments: Drug: allopurinol

Study type: Interventional

Funder types: Other

Identifiers

NCT01775098

Allopurinol in acute gout

Details and patient eligibility

About

The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

More than 18 years old Able to sign informed consent Indication of long-term treatment with allopurinol Acute gout crisis

Exclusion criteria

Les than 18 years-old Unable to consent Contra-indication to allopurinol

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

0 participants in 2 patient groups, including a placebo group

Allopurinol

Experimental group

Description:

treatment with allopurinol

Treatment:

Drug: allopurinol

placebo

Placebo Comparator group

Description:

placebo comparator

Treatment:

Drug: allopurinol